| Entry |
|
|---|
| Name |
Oprelvekin (USAN/INN);
Oprelvekin (genetical recombination) (JAN);
Neumega (TN) |
|---|
| Formula |
C854H1411N253O235S2
|
|---|
| Exact mass |
19035.5679
|
|---|
| Mol weight |
19047.03
|
|---|
| Sequence |
GPPPGPPRVS PDPRAELDST VLLTRSLLAD TRQLAAQLRD KFPADGDHNL DSLPTLAMSA
GALGALQLPG VLTRLRADLL SYLRHVQWLR RAGGSSLKTL EPELGTLQAR LDRLLRRLQL
LMSRLALPQP PPDPPAPPLA PPSSAWGGIR AAHAILGGLH LTLDWAVRGL LLLKTRL |
|---|
| Type |
Peptide |
|---|
| Remark |
|
|---|
| Efficacy |
Immunostimulant |
|---|
| Comment |
recombinant human interleukin-11
Hematopoietic stimulant
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AC Interleukins
L03AC02 Oprelvekin
D05266 Oprelvekin (USAN/INN)
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interleukin receptors
IL11RA
D05266 Oprelvekin (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
